The Scientist

» neurodegenerative diseases and culture

Most Recent

image: Notable Science Quotes

Notable Science Quotes

By | January 1, 2017

Science under Trump, gene drive, medical marijuana, and more

0 Comments

image: FDA Approves First Treatment for Spinal Muscular Atrophy

FDA Approves First Treatment for Spinal Muscular Atrophy

By | December 28, 2016

The oligonucleotide therapeutic will soon be available in the U.S.

0 Comments

image: Speaking of Science: 2016

Speaking of Science: 2016

By | December 19, 2016

Selected quotes from an eventful year

0 Comments

image: Trumping Science: Part II

Trumping Science: Part II

By | December 6, 2016

As Inauguration Day nears, scientists and science advocates are voicing their unease with the Trump Administration’s potential effects on research.

2 Comments

image: Gut Microbes Linked to Neurodegenerative Disease

Gut Microbes Linked to Neurodegenerative Disease

By | December 1, 2016

Bacteria in the intestine influence motor dysfunction and neuroinflammation in a mouse model of Parkinson’s disease.

3 Comments

image: Book Excerpt from <em>Redesigning Life</em>

Book Excerpt from Redesigning Life

By | December 1, 2016

In Chapter 8, author John Parrington explores the intersection of precision genome editing and stem cell technologies.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | December 1, 2016

The importance of science innovation, publishing and gender, and more

1 Comment

image: 2016 Top 10 Innovations: Honorable Mentions

2016 Top 10 Innovations: Honorable Mentions

By | December 1, 2016

These runners up to the Top 10 Innovations of 2016 caught our judges' attention.

0 Comments

image: Opinion: The Impact Factor, Re-envisioned

Opinion: The Impact Factor, Re-envisioned

By , , and | November 18, 2016

A combination of the traditional metric and the newer h5 index potentiates the scientific community toward more-balanced evaluation. 

2 Comments

image: New Support for Experimental Alzheimer’s Drug

New Support for Experimental Alzheimer’s Drug

By | November 2, 2016

Merck’s verubecestat, which is currently being tested in two Phase 3 studies, is safe, according to newly published Phase 1 data.

2 Comments

Popular Now

  1. Opinion: Why I Published in a Predatory Journal
    News & Opinion Opinion: Why I Published in a Predatory Journal

    My “colleagues” and I at the fictitious Arthur Vandelay Urological Research Institute were surprised to find our bogus “uromycitisis” case report swiftly accepted, with only minor revisions requested.

  2. Consilience, Episode 3: Cancer, Obscured
  3. March for Science: Dispatches from Washington, DC
  4. Record-Setting Corn Grows 45 Feet Tall
AAAS